Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleTheranostics

Detection Rate of 18F-Choline PET/CT and 68Ga-PSMA-HBED-CC PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph Nodes

Cordula A. Jilg, Vanessa Drendel, H. Christian Rischke, Teresa I. Beck, Kathrin Reichel, Malte Krönig, Ulrich Wetterauer, Wolfgang Schultze-Seemann, Philipp T. Meyer and Werner Vach
Journal of Nuclear Medicine July 2019, 60 (7) 971-977; DOI: https://doi.org/10.2967/jnumed.118.220541
Cordula A. Jilg
1Department of Urology, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vanessa Drendel
2Institute for Pathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Christian Rischke
3Department of Radiation Oncology, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Germany
4Department of Nuclear Medicine, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teresa I. Beck
4Department of Nuclear Medicine, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathrin Reichel
1Department of Urology, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Malte Krönig
1Department of Urology, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulrich Wetterauer
1Department of Urology, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Schultze-Seemann
1Department of Urology, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philipp T. Meyer
4Department of Nuclear Medicine, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Germany
5German Cancer Consortium (DKTK), Partner Site Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Werner Vach
6Department of Orthopedics and Traumatology, University Hospital Basel, Switzerland; and
7Institute for Medical Biometry and Statistics, Faculty of Medicine & Medical Center, University of Freiburg, Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 60 no. 7 971-977
DOI 
https://doi.org/10.2967/jnumed.118.220541
PubMed 
30683768

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online July 1, 2019.

Article Versions

  • previous version (January 25, 2019 - 08:28).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Cordula A. Jilg1,
  2. Vanessa Drendel2,
  3. H. Christian Rischke3,4,
  4. Teresa I. Beck4,
  5. Kathrin Reichel1,
  6. Malte Krönig1,
  7. Ulrich Wetterauer1,
  8. Wolfgang Schultze-Seemann1,
  9. Philipp T. Meyer4,5 and
  10. Werner Vach6,7
  1. 1Department of Urology, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
  2. 2Institute for Pathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany
  3. 3Department of Radiation Oncology, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Germany
  4. 4Department of Nuclear Medicine, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Germany
  5. 5German Cancer Consortium (DKTK), Partner Site Freiburg, Germany
  6. 6Department of Orthopedics and Traumatology, University Hospital Basel, Switzerland; and
  7. 7Institute for Medical Biometry and Statistics, Faculty of Medicine & Medical Center, University of Freiburg, Freiburg, Germany
  1. For correspondence or reprints contact: Cordula A. Jilg, Department of Urology, University of Freiburg, Hugstetterstraße 55, 79106 Freiburg, Germany. E-mail: cordula.jilg{at}uniklinik-freiburg.de
View Full Text

Statistics from Altmetric.com

Cited By...

  • 40 Citations
  • 47 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • 68Ga-PSMA PET/CT for Primary Lymph Node and Distant Metastasis NM Staging of High-Risk Prostate Cancer
    Søren Klingenberg, Mads R. Jochumsen, Benedicte P. Ulhøi, Jacob Fredsøe, Karina D. Sørensen, Michael Borre, Kirsten Bouchelouche
    Journal of Nuclear Medicine 2021 62 2
  • Recommandations françaises du Comité de cancérologie de l’AFU – actualisation 2020–2022 : cancer de la prostate
    F. Rozet, P. Mongiat-Artus, C. Hennequin, J.B. Beauval, P. Beuzeboc, L. Cormier, G. Fromont-Hankard, R. Mathieu, G. Ploussard, R. Renard-Penna, I. Brenot-Rossi, F. Bruyere, A. Cochet, G. Crehange, O. Cussenot, T. Lebret, X. Rebillard, M. Soulié, L. Brureau, A. Méjean
    Progrès en Urologie 2020 30 12
  • Multimodality Imaging of Prostate Cancer
    Soleen Ghafoor, Irene A. Burger, Alberto H. Vargas
    Journal of Nuclear Medicine 2019 60 10
  • Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen–radioguided Surgery
    Sophie Knipper, Mehrdad Mehdi Irai, Ricarda Simon, Daniel Koehler, Isabel Rauscher, Matthias Eiber, Fijs W.B. van Leeuwen, Pim van Leeuwen, Hilda de Barros, Henk van der Poel, Lars Budäus, Thomas Steuber, Markus Graefen, Pierre Tennstedt, Matthias M. Heck, Thomas Horn, Tobias Maurer
    European Urology 2023 83 1
  • Advances in Prostate‐Specific Membrane Antigen (PSMA)‐Targeted Phototheranostics of Prostate Cancer
    He Wang, Zhangxin He, Xiao-Ang Liu, Yuhua Huang, Jianquan Hou, Weijie Zhang, Dan Ding
    Small Structures 2022 3 8
  • 177Lu-PSMA radioligand therapy of predominant lymph node metastatic prostate cancer
    Finn Edler von Eyben, Aviral Singh, Jingjing Zhang, Karin Nipsch, Danielle Meyrick, Nat Lenzo, Kalevi Kairemo, Timo Joensuu, Irene Virgolini, Cigdem Soydal, Harshad R. Kulkarni, Richard Paul Baum
    Oncotarget 2019 10 25
  • Salvage therapy for prostate cancer after radical prostatectomy
    Nicholas G. Zaorsky, Jeremie Calais, Stefano Fanti, Derya Tilki, Tanya Dorff, Daniel E. Spratt, Amar U. Kishan
    Nature Reviews Urology 2021 18 11
  • PSMA PET/CT for Primary Staging of Prostate Cancer - An Updated Overview
    Mads Ryø Jochumsen, Kirsten Bouchelouche
    Seminars in Nuclear Medicine 2024 54 1
  • Head-to-Head Comparison of 68Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
    Melline G.M. Schilham, Patrik Zamecnik, Bastiaan M. Privé, Bas Israël, Mark Rijpkema, Tom Scheenen, Jelle O. Barentsz, James Nagarajah, Martin Gotthardt
    Journal of Nuclear Medicine 2021 62 9
  • Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting
    Andrea K. Miyahira, Kenneth J. Pienta, John W. Babich, Neil H. Bander, Jeremie Calais, Peter Choyke, Michael S. Hofman, Steven M. Larson, Frank I. Lin, Michael J. Morris, Martin G. Pomper, Shahneen Sandhu, Howard I. Scher, Scott T. Tagawa, Scott Williams, Howard R. Soule
    The Prostate 2020 80 15

Article usage

Article usage: January 2019 to May 2025

AbstractFullPdf
Jan 2019220023
Feb 2019850051
Mar 2019107029
Apr 2019106017
May 201964014
Jun 20194708
Jul 20199281468
Aug 2019233819
Sep 2019134616
Oct 2019102315
Nov 201964913
Dec 201955312
Jan 202056414
Feb 202043722
Mar 2020551619
Apr 2020331324
May 2020372126
Jun 2020351116
Jul 202035313
Aug 202023313
Sep 2020271215
Oct 20202859
Nov 202031812
Dec 2020141112
Jan 202191710
Feb 2021251913
Mar 2021231614
Apr 202191620
May 2021213010
Jun 2021201222
Jul 2021102620
Aug 2021104318
Sep 202191812
Oct 202181524
Nov 2021123035
Dec 2021222622
Jan 2022232916
Feb 2022102432
Mar 2022112411
Apr 2022182219
May 2022121226
Jun 2022142111
Jul 202252617
Aug 20225569
Sep 202265315
Oct 202267611
Nov 20226249
Dec 20228109
Jan 2023151811
Feb 202383122
Mar 2023122310
Apr 20239189
May 202391210
Jun 202372618
Jul 20234139
Aug 202351012
Sep 2023776
Oct 202382411
Nov 20236188
Dec 20232336
Jan 20248106
Feb 20243194
Mar 202461827
Apr 2024713517
May 202423618
Jun 202472012
Jul 202452217
Aug 202473615
Sep 202443413
Oct 2024102116
Nov 202462213
Dec 202452914
Jan 202572520
Feb 202566115
Mar 202534416
Apr 202572933
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 60 (7)
Journal of Nuclear Medicine
Vol. 60, Issue 7
July 1, 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Detection Rate of 18F-Choline PET/CT and 68Ga-PSMA-HBED-CC PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph Nodes
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Detection Rate of 18F-Choline PET/CT and 68Ga-PSMA-HBED-CC PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph Nodes
Cordula A. Jilg, Vanessa Drendel, H. Christian Rischke, Teresa I. Beck, Kathrin Reichel, Malte Krönig, Ulrich Wetterauer, Wolfgang Schultze-Seemann, Philipp T. Meyer, Werner Vach
Journal of Nuclear Medicine Jul 2019, 60 (7) 971-977; DOI: 10.2967/jnumed.118.220541

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Detection Rate of 18F-Choline PET/CT and 68Ga-PSMA-HBED-CC PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph Nodes
Cordula A. Jilg, Vanessa Drendel, H. Christian Rischke, Teresa I. Beck, Kathrin Reichel, Malte Krönig, Ulrich Wetterauer, Wolfgang Schultze-Seemann, Philipp T. Meyer, Werner Vach
Journal of Nuclear Medicine Jul 2019, 60 (7) 971-977; DOI: 10.2967/jnumed.118.220541
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Pattern of Failure in Patients with Biochemical Recurrence After PSMA Radioguided Surgery
  • Head-to-Head Comparison of 68Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10-Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
  • Reply: The Importance of an Adequate Surgical Template During Salvage Lymph Node Dissection for Node-Recurrent Prostate Cancer
  • 68Ga-PSMA PET/CT for Primary Lymph Node and Distant Metastasis NM Staging of High-Risk Prostate Cancer
  • Multimodality Imaging of Prostate Cancer
  • Google Scholar

More in this TOC Section

Theranostics

  • Can 177Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data
  • Determination of the Intralesional Distribution of Theranostic 124I-Omburtamab Convection-Enhanced Delivery in Treatment of Diffuse Intrinsic Pontine Glioma
  • Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
Show more Theranostics

Clinical

  • Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
  • SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
  • Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
Show more Clinical

Similar Articles

Keywords

  • prostate cancer
  • lymph node metastases
  • PSMA-PET/CT
  • choline-PET/CT
  • detection rate
SNMMI

© 2025 SNMMI

Powered by HighWire